GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Pretax Margin %

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Pretax Margin % : -437.17% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ginkgo Bioworks Holdings's Pre-Tax Income for the three months ended in Mar. 2024 was $-165.88 Mil. Ginkgo Bioworks Holdings's Revenue for the three months ended in Mar. 2024 was $37.94 Mil. Therefore, Ginkgo Bioworks Holdings's pretax margin for the quarter that ended in Mar. 2024 was -437.17%.

The historical rank and industry rank for Ginkgo Bioworks Holdings's Pretax Margin % or its related term are showing as below:

DNA.WS' s Pretax Margin % Range Over the Past 10 Years
Min: -585.69   Med: -355.11   Max: -162.85
Current: -409.17


DNA.WS's Pretax Margin % is ranked worse than
61.96% of 1028 companies
in the Biotechnology industry
Industry Median: -155.98 vs DNA.WS: -409.17

Ginkgo Bioworks Holdings Pretax Margin % Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Pretax Margin % Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
-221.16 -162.85 -585.69 -444.08 -355.11

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -253.88 -215.03 -546.48 -609.67 -437.17

Competitive Comparison of Ginkgo Bioworks Holdings's Pretax Margin %

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's Pretax Margin % falls into.



Ginkgo Bioworks Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ginkgo Bioworks Holdings's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-892.94/251.455
=-355.11 %

Ginkgo Bioworks Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-165.88/37.944
=-437.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ginkgo Bioworks Holdings  (NYSE:DNA.WS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Ginkgo Bioworks Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.